Heng Chan - DSS Chairman of the Board
| DSS Stock | USD 1.07 0.05 4.90% |
Chairman
Mr. Heng Fai Chan serves as Chairman of the Board of the Company. On September 11, 2017, Mr. Chan and the Company entered into an agreement whereby Mr. Chan also serves as the Chief Executive Officer of the Companys whollyowned subsidiary, DSS International Inc. Mr. Chan is an expert in banking and finance, with years of experience in the industry. Mr. Chan has restructured 35 companies in various industries and countries in the past 40 years. Mr. Chan currently serves as the Chief Executive Officer of Singapore eDevelopment Limited, a publicly traded company on the Singapore Stock Exchange. He also serves as a director of BMI Capital Partners International Ltd., a whollyowned subsidiary of SED since 2019.
| Age | 79 |
| Tenure | 5 years |
| Address | 275 Wiregrass Parkway, West Henrietta, NY, United States, 14586 |
| Phone | 585 325 3610 |
| Web | https://www.dssworld.com |
Latest Insider Transactions
Chan also serves on the board of Holista CollTech Limited, a publicly traded company listed on the Australian Securities Exchange.Mr. Chan formerly served as Managing Chairman of Heng Fai Enterprises Limited which trades on the Hong Kong Stock Exchange; the Managing Director of SGX Catalistlisted SingHaiyi Group Ltd. the Executive Chairman of China Gas Holdings Limited, a formerly failing fashion retail company listed on the Hong Kong Stock Exchange, which under his direction, was restructured to become one of the few large participants in the investment in and operation of city gas pipeline infrastructure in China; a director of Global Med Technologies, IncHeng Chan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Heng Chan against DSS stock is an integral part of due diligence when investing in DSS. Heng Chan insider activity provides valuable insight into whether DSS is net buyers or sellers over its current business cycle. Note, DSS insiders must abide by specific rules, including filing SEC forms every time they buy or sell DSS'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Heng Chan over a month ago Acquisition by Heng Chan of 1226 shares of Alset Ehome at 1.3 subject to Rule 16b-3 | ||
Heng Chan over a month ago Acquisition by Heng Chan of 10000 shares of Alset Ehome at 1.72 subject to Rule 16b-3 | ||
Heng Chan over a month ago Acquisition by Heng Chan of 5558347 shares of HWH International at 0.63 subject to Rule 16b-3 | ||
Heng Chan over three months ago Acquisition by Heng Chan of 12867 shares of Alset Ehome at 1.17 subject to Rule 16b-3 |
DSS Management Efficiency
The company has Return on Asset of (0.0692) % which means that on every $100 spent on assets, it lost $0.0692. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5897) %, meaning that it generated no profit with money invested by stockholders. DSS's management efficiency ratios could be used to measure how well DSS manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.8 in 2024. Return On Capital Employed is likely to gain to -0.21 in 2024. At this time, DSS's Fixed Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Found 10 records | CHAIRMAN Age | ||
| Daniel Gunsett | Greif Bros | 72 | |
| Mark Kowlzan | Packaging Corp of | 68 | |
| John Conway | Crown Holdings | 75 | |
| Jerry Whitaker | Sealed Air | 70 | |
| Michael Gasser | Greif Bros | 69 | |
| F Liebau | Myers Industries | 57 | |
| John Walker | O I Glass | 62 | |
| Paul Stecko | Packaging Corp of | 75 | |
| John Haley | Sonoco Products | 59 | |
| Joseph Abbandonato | Imaflex | N/A | |
Management Performance
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.0692 |
DSS Inc Leadership Team
Elected by the shareholders, the DSS's board of directors comprises two types of representatives: DSS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DSS. The board's role is to monitor DSS's management team and ensure that shareholders' interests are well served. DSS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DSS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Sanders, Independent Director | ||
| Todd Macko, Interim Chief Financial Officer | ||
| BApSc MBA, President Director | ||
| John Thatch, Non-Executive Independent Director | ||
| William Wu, Non-Executive Independent Director | ||
| Tung Chan, Director | ||
| JD Esq, CEO Director | ||
| Melissa Sims, Chief Title | ||
| Kan Lum, Pres Asia | ||
| Julia Graf, Director Resources | ||
| Jason Grady, Chief Operating Officer | ||
| Jose Escudero, Non-Executive Independent Director | ||
| Heng Chan, Chairman of the Board | ||
| Frank JD, CEO Director | ||
| Wah Lo, Non-Executive Director | ||
| Fai Chan, Executive Board | ||
| Sassuan Lee, Non-Executive Independent Director | ||
| Frank Heuszel, Chief Executive Officer, Interim Chief Financial Officer, Director | ||
| Travis Heuszel, Legal Manager |
DSS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DSS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.0692 | ||||
| Profit Margin | (2.25) % | ||||
| Operating Margin | (1.18) % | ||||
| Current Valuation | 59.99 M | ||||
| Shares Outstanding | 7.07 M | ||||
| Shares Owned By Insiders | 59.27 % | ||||
| Shares Owned By Institutions | 2.40 % | ||||
| Number Of Shares Shorted | 11.49 K | ||||
| Price To Earning | 0.68 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for DSS Stock Analysis
When running DSS's price analysis, check to measure DSS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DSS is operating at the current time. Most of DSS's value examination focuses on studying past and present price action to predict the probability of DSS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DSS's price. Additionally, you may evaluate how the addition of DSS to your portfolios can decrease your overall portfolio volatility.